Satu Tiainen
Visiting Researcher
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
Publications
11/11 items-
Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non–Small Cell Lung Cancer: A Retrospective Real-World Study
Paappanen, V; Järvenpää, H; Jukkola, A; Päkkilä, P; Sahlström, S; Klaavuniemi, T; Sailas, L; Ahvonen, J; Kuitunen, H; Kopra, J; Kuittinen, O; Tengström, M; Tiainen, S, 2025, Clinical oncology, 47, 103930. A1 Journal article (refereed), original research -
Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study
Paappanen, Ville; Tikka, Jenny; Jukkola, Arja; Klaavuniemi, Tuula; Sailas, Liisa; Tengström, Maria; Kuitunen, Hanne; Riekkinen, Teemu; Tiainen, Satu; Kuittinen, Outi, 2025, Acta oncologica, 64, 909-916. A1 Journal article (refereed), original research -
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events
Nurmela, Veera; Juntunen, Anni; Selander, Tuomas; Pasonen-Seppänen, Sanna; Kuittinen, Outi; Tiainen, Satu; Rönkä, Aino, 2025, Immunotherapy, 17, 5, 339-346. A1 Journal article (refereed), original research -
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer
Jääskeläinen, Minna M; Tumelius, Ritva; Hämäläinen, Kirsi; Rilla, Kirsi; Oikari, Sanna; Rönkä, Aino; Selander, Tuomas; Mannermaa, Arto; Tiainen, Satu; Auvinen, Päivi, 2024, Cancers, 16, 3, 634. A1 Journal article (refereed), original research -
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Tiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino, 2023, Bmc cancer, 23, 1, 1186. A1 Journal article (refereed), original research -
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
Jääskeläinen, Minna M; Tiainen, Satu; Siiskonen, Hanna; Ahtiainen, Maarit; Kuopio, Teijo; Rönkä, Aino; Kettunen, Tiia; Hämäläinen, Kirsi; Rilla, Kirsi; Harvima, Ilkka; Mannermaa, Arto; Auvinen, Päivi, 2023, Breast cancer research and treatment, 201, 183-192. A1 Journal article (refereed), original research -
Inflammation and glucose metabolism in breast cancer
Tiainen, Satu, 2022, Publications of the University of Eastern Finland. Dissertations in Health Sciences. G5 Doctoral dissertation (article) -
The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
Tiainen, Satu; Rilla, Kirsi; Hämäläinen, Kirsi; Oikari, Sanna; Auvinen, Päivi, 2020, Breast cancer research and treatment, 2021; 185, 63-72. A1 Journal article (refereed), original research -
Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors
Iivanainen, Sanna; Ahvonen, Jarkko; Knuuttila, Aija; Tiainen, Satu; Koivunen, Jussi Pekka, 2019, ESMO open, 4, e000531. A1 Journal article (refereed), original research -
Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis
Tiainen, S; Masarwah, A; Oikari, S; Rilla, K; Hämäläinen, K; Sudah, M; Sutela, A; Vanninen, R; Ikonen, J; Tammi, R; Tammi, M; Auvinen, P, 2019, Breast cancer research and treatment, 2020; 179, 565-575. A1 Journal article (refereed), original research